Dan O. Cohen
6 Weizmann St, 6423906
Tel Aviv, TA 64239, Israel
Tel Aviv, TA 64239, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Beyond Visual Assessment of Basal Ganglia Uptake: Can Automated Method and Pineal Body Uptake Assessment Improve Identification of Nigrostriatal Dysfunction on 18F-DOPA PET/CT?
Journal: International journal of molecular sciences
Published: February 21, 2023
Staging Prostate Cancer with 68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 25, 2022
MRI reporter genes in the era of gene transfer.
Journal: Clinical and translational medicine
Published: November 10, 2022
PET radiotracers for whole-body in vivo molecular imaging of prostatic neuroendocrine malignancies.
Journal: European radiology
Published: September 13, 2022
A lesson in humility: the added values of PET-MRI over PET-CT in detecting malignant hepatic lesions.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 11, 2022
Lymphoma pseudoprogression observed on [18F]FDG PET-CT scan 15 days after CAR-T infusion.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 10, 2022
Is There a Role for [18F]FDG PET-CT in Staging MALT Lymphoma?
Journal: Cancers
Published: November 30, 2021
A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [18F]FDG PET-CT studies performed in oncologic patients.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 30, 2021
[18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 24, 2021
Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 05, 2021
Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 04, 2021
Last Updated: 09/26/2026